首页> 外文OA文献 >A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer

【2h】

A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer

机译：术前低癌症抗原125水平（≤25.8mg/ dl）是一种有用的标准，以确定新辅助化疗在上皮性卵巢癌中的新辅助化疗后的间隔减少手术的最佳时间

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Akemi Morimoto; Shoji Nagao; Ai Kogiku; Kasumi Yamamoto; Maiko Miwa; Senn Wakahashi; Kotaro Ichida; Tamotsu Sudo; Satoshi Yamaguchi; Kiyoshi Fujiwara;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A preoperative low cancer antigen 125 level (a parts per thousand currency sign25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer [J] . Morimoto Akemi, Nagao Shoji, Kogiku Ai, Japanese journal of clinical oncology. . 2016,第6期

机译：术前低癌抗原125水平（千分之一货币符号25.8 mg / dl）是确定上皮性卵巢癌新辅助化疗后间隔减瘤手术的最佳时机的有用标准
2. Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection [J] . Gill Sarah E., McGree Michaela E., Weaver Amy L., Gynecologic Oncology: An International Journal . 2017,第2期

机译：优化卵巢癌的治疗：新辅助化疗和间隔去除对上皮性卵巢癌的初级剥离手术可能具有次优切除术
3. Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery An Italian Multicenter Retrospective Study [J] . Gadducci Angiolo, Cosio Stefania, Zizioli Valentina, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2017,第1期

机译：在初级消泡手术加上化疗或Neoadjuvant化疗后，II阶段II阶段阶段IV阶段上皮卵巢癌的患者的复发和临床结果的临床结果
4. Analysis of Oncologic Outcomes Associated with Anti-adhesion Sodium Hyaluronate-Carboxymethylcellulose Barrier Following Optimal or Complete Cytoreductive Surgery for Ovarian, Fallopian Tube, and Peritoneal Cancers. [D] . Krill, Lauren. 2014

机译：卵巢癌，输卵管癌和腹膜癌的最佳或完全细胞还原手术后，与抗粘连透明质酸钠-羧甲基纤维素屏障相关的肿瘤学结果分析。
5. Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer [O] . Aurélie Pelissier, Aurélie Roulot, Béatrice Guéry, 2016

机译：血清CA125和HE4水平可作为晚期上皮性卵巢癌患者新辅助铂类化疗后最佳间隔手术和铂敏感性的预测指标
6. Patterns of Recurrence and Clinical Outcome of Patients with Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response after Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study [O] . Gadducci Angiolo, Cosio Stefania, Zizioli Valentina, 2017

机译：原发性减瘤手术加化学疗法或新辅助化疗后间隔减瘤手术后，IIIC期至IV期上皮性卵巢癌完全缓解的复发模式和临床结局：意大利多中心回顾性研究

A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer

著录项

引文网络

相似文献

相关主题

期刊订阅